Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
TARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first quarter earnings release on Thursday, August 8, 2024 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
普雷斯蒂奇消費保健公司（NYSE：PBH）今日宣佈，將於2024年8月8日（星期四）早盤開市前發佈2025財年第一季度業績，公司將於當天上午8:30 ET召開電話會議討論業績結果。
To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of . To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.
爲參加電話會議的網絡直播，請登錄投資者關係頁面。參加電話會議的人可以在這裏註冊，以獲取撥號詳情和獨特的PIN碼。雖然不是必需的，但建議提前10分鐘加入，以免錯過任何重要信息。
A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company's Investor Relations page.
電話會議重播將於直播結束後大約一週內提供，並可在公司的投資者關係頁面上訪問。
About Prestige Consumer Healthcare Inc.
關於普雷斯蒂奇公司
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company's diverse portfolio of brands include Monistat and Summer's Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart treatments, Little Remedies pediatric over-the-counter products, Boudreaux's Butt Paste diaper rash ointments, Nix lice treatment, Debrox earwax remover, Gaviscon antacid in Canada, and Hydralyte rehydration products and the Fess line of nasal and sinus care products in Australia. Visit the Company's website at .
普雷斯蒂奇消費保健公司將消費保健產品銷售、製造和分銷到美國和加拿大的零售店，澳大利亞以及某些其他國際市場。公司的品牌組合包括Monistat和Summer's Eve女性保健產品，BC和Goody's止痛藥，Clear Eyes和TheraTears眼部護理產品，DenTek特殊口腔護理產品，Dramamine暈動病治療，Fleet灌腸和甘油栓，Chloraseptic和Luden的喉嚨治療和口腔消毒藥物，Compound W疣的治療，Little Remedies小兒用成藥，Boudreaux's Butt Paste尿布疹藥，Nix殺蝨劑，Debrox耳垢清除劑，Gaviscon加拿大抗酸劑，以及澳大利亞的Hydralyte補水產品和Fess系列的鼻腔和鼻竇護理產品。請訪問公司的網站。
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com
投資者關係聯繫人
Phil Terpolilli，CFA，914-524-6819
irinquiries@prestigebrands.com
Source: Prestige Consumer Healthcare Inc.
來源：普雷斯蒂奇公司。
譯文內容由第三人軟體翻譯。